In a nutshell: The hottest developments in the field of cardiology in 2020. Section 5. Coronary artery disease dr. Abhimanyu Uppal31 Dec 2020 11:00 AM ISTCoronary artery disease (CAD) management id undoubtedly the most impactful arena of interventional cardiology. This year we witnessed several...
Hottest developments in field of cardiology in 2020 in nutshell. Section 4- Structural Heart disease dr. Abhimanyu Uppal29 Dec 2020 7:52 AM ISTThe year 2020 earmarked the expanding realm of transcatheter interventions to address aortic, tricuspid, and mitral valvular lesions and provide...
Avoiding Aldosterone Breakthrough in Hypertensive Diabetics: Role of Azelnidipine Dr. Prem Aggarwal28 Dec 2020 12:30 PM ISTAzelnidipine may contribute to avoid the "aldosterone breakthrough" by its suppressive effects on aldosterone synthesis and secretion
Hottest developments in the field of cardiology in 2020. Section 3: Heart failure dr. Abhimanyu Uppal25 Dec 2020 9:15 PM ISTInteresting developments have shown promise to improve the management of heart failure in 2020. From introducing the arrival of myosin inhibitors in...
2020 in a nutshell: The hottest developments in field of cardiology this year. Section 2. Atrial fibrillation dr. Abhimanyu Uppal25 Dec 2020 8:45 AM ISTExciting researches continue to swirl around the niche of atrial fibrillation and its management. The year 2020 marked the advent of cryoablation as a...
2020 in a nutshell: The hottest developments in the field of cardiology this year. Section 1. General and preventive cardiology dr. Abhimanyu Uppal24 Dec 2020 12:45 PM ISTFrom addressing the concerns of ACE inhibitors in the COVID19 era to defining a new target population for antihypertensive treatment, the following...
Impact of Azelnidipine in reducing urinary albumin excretion and carotid atherosclerosis in type 2 diabetes patients: BOAT 2 study Review Dr. Prem Aggarwal15 Dec 2020 12:45 PM ISTHypertension and Diabetes Mellitus are the global health burden and strong risk factors for coronary artery disease (1). Impaired glucose tolerance...
Use of Probiotics in the Management of Hypertension - Exploring the Potential Hina Zahid10 Dec 2020 12:45 PM ISTHypertension has become a common chronic medical condition affecting > 20% of adult population worldwide. It is certainly established to be a...
Azelnidipine versus Amlodipine in hypertensive diabetics with albuminuria: Review Dr. Prem Aggarwal27 Nov 2020 12:45 PM ISTHypertension is common among diabetics and those who have chronic kidney disease. Both hypertension and diabetes are associated with increased...
Hypertension in Diabetes: Considering Therapies which Optimise Kidney Protection Dr Sujoy Ghosh20 Nov 2020 11:25 AM ISTHypertension and Diabetes remain the top two causes of End-Stage Renal Disease (ESRD) (1). Hence, it seems clinically appropriate to establish that...
Hypertension and Kidney: Choosing the Right Therapeutic Agent for BP Control and Nephroprotection Dr. Arun Shah11 Nov 2020 11:30 AM ISTIn the management of hypertension, the treatment goals need to be dual with equal emphasis – i.e. to reduce the blood pressure levels and provide...
Role of Azelnidipine on management of BP in hypertensive Diabetics: Review Dr. Prem Aggarwal4 Nov 2020 11:09 AM ISTHypertensive patients with type 2 diabetes carry a high cardiovascular risk. Most patients with hypertension and diabetes face higher mortality due to...
